Public Sector Pension Investment Board (PSP Investments)’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-286,953
Closed -$3.72M 1439
2021
Q2
$3.72M Sell
286,953
-9,160
-3% -$117K 0.02% 739
2021
Q1
$3.85M Sell
296,113
-8,600
-3% -$125K 0.02% 617
2020
Q4
$4.2M Sell
304,713
-4,487
-1% -$65.3K 0.03% 538
2020
Q3
$4.54M Buy
309,200
+38,700
+14% +$561K 0.04% 447
2020
Q2
$4.4M Buy
+270,500
New +$4.33M 0.04% 420

Other funds holding AUPH

Public Sector Pension Investment Board (PSP Investments)'s AUPH Position: Q3 2021 in Review

Public Sector Pension Investment Board (PSP Investments) sold out of Aurinia Pharmaceuticals (AUPH) in Q3 2021, closing a stake of 286,953 shares — an estimated $3.72M sold.

Public Sector Pension Investment Board (PSP Investments) first reported a position in AUPH in Q2 2020 and held it in 5 quarters. The position peaked at $4.54M in Q3 2020. 166 funds tracked by Wall St. Rank hold AUPH as of Q3 2021.

  • Public Sector Pension Investment Board (PSP Investments) reported no remaining Aurinia Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Public Sector Pension Investment Board (PSP Investments) sold 286,953 Aurinia Pharmaceuticals shares in Q3 2021, an estimated $3.72M.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in Aurinia Pharmaceuticals in Q2 2020 and held it in 5 quarters.
  • Public Sector Pension Investment Board (PSP Investments)'s Aurinia Pharmaceuticals position peaked at $4.54M in Q3 2020.
  • 166 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2021.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q3 2021, filed 12 Nov 2021.